Sadahito Shin, Deceased

Title: Sadahito Shin: A Legacy of Innovation in Genetic Research

Introduction

Sadahito Shin was a notable inventor in the field of genetic research, known for his contributions to the understanding of transcription regulation. He was based in Tokushima-ken, Japan, and held a total of 3 patents during his career. His work has had a lasting impact on the diagnosis and treatment of hereditary diseases.

Latest Patents

One of his significant patents includes the FK506-binding protein gene, specifically the hTFIIIA gene. This isolated hTFIIIA gene possesses a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1, with particular emphasis on the hTFIIIA gene having the nucleotide sequence of SEQ ID NO:2. The gene is instrumental in expressing the corresponding hTFIIIA protein, which serves as a transcription regulating factor. This innovation is particularly useful in diagnosing hereditary diseases, such as cancer, and in analyzing the mechanisms of transcriptional control.

Career Highlights

Sadahito Shin worked at Otsuka Pharmaceutical Company, Limited, where he made significant strides in genetic research. His work has contributed to advancements in understanding how transcriptional control can affect health and disease.

Collaborations

Throughout his career, he collaborated with notable colleagues, including Tsutomu Fujiwara and Shiro Okuno. These collaborations helped to enhance the research and development of innovative solutions in the field of genetics.

Conclusion

Sadahito Shin's contributions to genetic research and his innovative patents have left a lasting legacy in the scientific community. His work continues to influence the diagnosis and treatment of hereditary diseases today.